Cargando…
KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control
The utility of KRAS mutations in plasma circulating cell-free DNA (cfDNA) samples as non-invasive biomarkers for the detection of pancreatic cancer has never been evaluated in a large case-control series. We applied a KRAS amplicon-based deep sequencing strategy combined with analytical pipeline spe...
Autores principales: | Le Calvez-Kelm, Florence, Foll, Matthieu, Wozniak, Magdalena B., Delhomme, Tiffany M., Durand, Geoffroy, Chopard, Priscilia, Pertesi, Maroulio, Fabianova, Eleonora, Adamcakova, Zora, Holcatova, Ivana, Foretova, Lenka, Janout, Vladimir, Vallee, Maxime P., Rinaldi, Sabina, Brennan, Paul, McKay, James D., Byrnes, Graham B., Scelo, Ghislaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346680/ https://www.ncbi.nlm.nih.gov/pubmed/27705932 http://dx.doi.org/10.18632/oncotarget.12386 |
Ejemplares similares
-
Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA
por: Zvereva, Maria, et al.
Publicado: (2020) -
Integrative Genome-Wide Gene Expression Profiling of Clear Cell Renal Cell Carcinoma in Czech Republic and in the United States
por: Wozniak, Magdalena B., et al.
Publicado: (2013) -
Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data
por: Delhomme, Tiffany M, et al.
Publicado: (2020) -
Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma
por: Vinayanuwattikun, Chanida, et al.
Publicado: (2016) -
Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma
por: Laskar, Ruhina S, et al.
Publicado: (2021)